Edible mushroom fermentation extract as well as preparation method and application thereof

Through co-fermentation technology of mold, yeast and lactic acid bacteria, combined with the use of bacterial promoters, the preparation process of edible fungi extracts is optimized, and the problem of low yield of active ingredients in the existing technology is solved, which significantly improves the organisms of edible fungi extracts Active and functional, suitable for food, health products and medicine.

CN118975661APending Publication Date: 2024-11-19QINGDAO BNP BIOSCIENCE CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411048246.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The current active ingredient yield of edible fungi extracts is low, and there is no method to prepare edible fungi fermentation extracts through co-fermentation of mold, yeast, and lactic acid bacteria, which limits the improvement and diversity of the biologically active ingredients of edible fungi.

Method used

Using co-fermentation technology of mold, yeast and lactic acid bacteria, the types and content of active ingredients in edible fungi extracts are improved by optimizing fermentation conditions and the addition of bacterial promoters, including high-temperature sterilization, ultrasonic extraction and multi-stage fermentation steps, combined with the promotion of The use of bacterial factors such as complex extracts, prebiotics and pyridoxal phosphate enhances strain proliferation and metabolic capacity.

Benefits of technology

It significantly improves the content of biologically active substances such as polysaccharides, adenosines, and polyphenols in edible fungi extracts, improves its functions such as lowering blood sugar and blood lipids, simplifies process operations, facilitates industrial production, and enhances the application value of the products. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118975661A_ABST
    Figure CN118975661A_ABST
Patent Text Reader

Abstract

The invention provides an edible mushroom fermentation extract as well as a preparation method and application thereof, and belongs to the technical field of food processing. According to the method, common edible mushroom sporocarp is used as a raw material, and the edible mushroom fermentation extract is prepared through a multi-strain co-fermentation technology. The method comprises the following steps: crushing and sieving dried sporocarp of edible mushrooms, and adding a bacterium promoting factor to prepare a fermentation culture medium; inoculating the activated strain into a fermentation culture medium for co-fermentation culture, sterilizing and filtering to obtain fermentation liquor, mixing the fermentation liquor with auxiliary materials, and drying to obtain the edible mushroom fermentation extract. A fermentation technology is introduced into a preparation process of the edible fungus extract, the edible fungus fermentation extract rich in polysaccharide, beta-glucan, polyphenol, adenosine and GABA (gamma-aminobutyric acid) is obtained, and the edible fungus fermentation extract has remarkable effects of reducing blood sugar and blood fat.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of food processing, and in particular relates to an edible fungus fermentation extract and a preparation method and application thereof. Background Art

[0002] Common edible fungi include Ganoderma lucidum, Hericium erinaceus, Cordyceps sinensis, Lentinula edodes, Grifola frondosa, Pleurotus eryngii, Tremella fuciformis, etc. They are rich sources of phytonutrients, including polysaccharides, triterpenoid saponins, flavonoids, alkaloids, nucleotides and polyphenols, and their extracts have biological activities such as immunomodulation, anti-tumor, anti-virus, antioxidant, and lowering blood sugar and blood lipids. Although edible fungi can be cultivated artificially, the mycelium and fruiting bodies grow slowly and have low yields.

[0003] In the modern fungi industry, the emergence of factory-based liquid fermentation has become an important symbol of the progress of the edible fungi industry. Researchers use liquid fermentation culture mode to conduct technical research and development on the rich and diverse secondary metabolites in edible fungi fermentation liquid. Edible fungi or their extracts are used as fermentation substrates, and suitable microorganisms are selected as fermentation strains. The biotransformation effect of probiotics can effectively increase the content of bioactive ingredients in edible fungi, enhance their biological activity or produce new active ingredients. However, based on liquid fermentation of a single edible fungi strain, the yield of effective ingredients is low, and there is no method reported to prepare edible fungi fermentation extracts by co-fermentation of mold, yeast, and lactic acid bacteria. Summary of the invention

[0004] The present invention provides an edible fungus fermentation extract and a preparation method and application thereof. The method optimizes the preparation process of the edible fungus extract by introducing microbial fermentation, effectively increases the types and contents of effective ingredients in the edible fungus extract, improves the quality and effect of the edible fungus extract, and has simple process operation, good practical value and application prospect.

[0005] In order to achieve the above object, the present invention provides a method for preparing an edible fungus fermentation extract, which is prepared by the following steps:

[0006] The edible fungus fruiting bodies are crushed and sieved to obtain 80-100 mesh crushed materials, which are soaked in water at a material-liquid ratio of 1:5-10, bacteriostatic factors are added, the pH is adjusted to 6.5±0.5, and the mixture is stirred evenly and sterilized at high temperature to obtain a fermentation substrate containing the edible fungus fruiting bodies;

[0007] The activated mold liquid, yeast liquid and lactic acid bacteria liquid are added into a fermentation tank according to a certain ratio, fermented for 72 to 120 hours, and then sterilized to terminate the fermentation to obtain a fermentation product;

[0008] The fermentation product is subjected to ultrasonic extraction and plate-and-frame filtration treatment, concentrated to obtain a fruiting body fermentation extract, and auxiliary materials are added or not, and the product is dried and sieved to obtain an edible fungus fermentation extract.

[0009] In the above scheme, high temperature sterilization can be performed at 115°C to 121°C for 15 to 30 minutes. In addition, the activation steps of molds, yeasts and lactic acid bacteria can all be performed using common activation processes in the fermentation field, for example, 100 μL of glycerol culture of the fermentation bacteria is spread and cultured in the corresponding solid plate culture medium, and a single colony in the cultured plate is inoculated in a liquid culture medium for centralized activation to obtain an activated culture solution.

[0010] Preferably, the edible fungus is selected from at least one of Hericium erinaceus, Ganoderma lucidum, Cordyceps sinensis, Matsutake, Lentinula edodes, Grifola frondosa, Inonotus obliquus, Agaricus blazei, Coprinus comatus, Agaricus bisporus and Pleurotus eryngii.

[0011] Preferably, the bacteriostatic factors include: 3-15 g / L compound extract, 10-20 g / L prebiotics, 7-10 g / L peptone, 2.4-4 g / L sodium glutamate, 5-10 mg / L pyridoxal phosphate; wherein:

[0012] The composite extract is wolfberry extract: yam extract: chrysanthemum extract = 5:3:2, w / w;

[0013] Prebiotics are fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2, w / w.

[0014] It is understandable that wolfberry extract, yam extract and chrysanthemum extract, as natural plant extracts, are rich in plant polysaccharides, alkaloids, amino acids, and vitamins, which can promote the proliferation of fermentation bacteria.

[0015] Preferably, the mold is selected from at least one of CICC 2626 Trichoderma reesei and CICC 24512 Bacillus subtilis; the yeast is selected from at least one of CICC 1338 and CICC 32883 Saccharomyces cerevisiae; and the lactic acid bacteria is selected from at least one of CICC 25096 Lactobacillus rhamnosus and CICC 22158 Lactobacillus plantarum.

[0016] It can be understood that the mold selected in the above scheme can self-produce acid cellulase and β-glucosidase, the selected can metabolize to produce ergosterol, and the selected lactic acid bacteria can metabolize to produce glutamate decarboxylase, which is a pyridoxal phosphate-dependent enzyme that can catalyze the decarboxylation of glutamate and glutamate salts in the culture medium to produce γ-aminobutyric acid in an acidic environment.

[0017] Preferably, the number of viable bacteria in the mold solution, yeast solution and lactic acid bacteria solution is not less than 10 8CFU / mL, the total inoculation amount is 7% to 12% of the total volume of the fermentation liquid, and the inoculation volume ratio of mold, yeast and lactic acid bacteria liquid is 1 to 2:4 to 5:3 to 4.

[0018] Preferably, the co-fermentation step comprises four stages, namely:

[0019] The dominant bacteria in the first stage of fermentation are molds, the fermentation temperature is 30±2℃, the rotation speed is 180~200rpm, and the pH changes to 5.5±0.5 during the fermentation process;

[0020] The dominant strain in the second stage fermentation is yeast, the fermentation temperature is 30±2℃, the rotation speed is 100~130rpm, and the pH remains basically unchanged during the fermentation process;

[0021] The dominant bacteria in the third stage fermentation were lactic acid bacteria, the fermentation temperature was 37±2℃, the fermentation was allowed to stand, and the pH changed to 4.0±0.5 during the fermentation process;

[0022] The temperature is raised to 70±5℃ in the fourth stage, and the rotation speed is 150~180rpm.

[0023] It can be understood that in the above fermentation process, the segmented fermentation mode enables the dominant bacteria in each stage to exert the greatest effect. In the first stage, the mold proliferates and produces cellulase and glucosidase, and the enzyme amount gradually accumulates during the fermentation process; in the second stage, the yeast proliferates rapidly and consumes the monosaccharide components in the fermentation substrate; in the third stage, lactic acid bacteria produce acid, and the low pH inhibits the proliferation of the other two bacteria. At the same time, the lactic acid bacteria metabolize and produce GABA; in the fourth stage, the optimal reaction conditions of the enzyme system are achieved by raising the temperature, destroying the fruiting body structure, promoting the dissolution of the effective active ingredients in the content, and at the same time achieving an extraction effect.

[0024] Preferably, the frequency of the ultrasound is 25-30 kHz, and the extraction time is 20-30 min.

[0025] Preferably, the drying is at least one of vacuum drying, spray drying, microwave drying and freeze drying.

[0026] Preferably, the auxiliary material in the drying process is at least one of maltodextrin, starch, resistant dextrin and polydextrose.

[0027] The present invention also provides an edible fungus fermentation extract, characterized in that it is prepared by the method described in any one of the above technical solutions.

[0028] Preferably, the edible fungus fermentation extract has a crude polysaccharide content of 10-40%, a β-glucan content of 10-30%, a total polyphenol content of 1-1.5%, adenosine content of 0.8-1.2%, and a GABA content of 2.5-4 mg / g.

[0029] The present invention also provides a use of the edible fungus fermentation extract according to any of the above technical solutions in functional foods, health products or medicines for assisting in the treatment of lowering blood sugar, lowering blood lipids and promoting sleep.

[0030] Unless otherwise specified, all reagents and raw materials used in the present invention are commercially available products or products that can be prepared by known methods.

[0031] Compared with the prior art, the advantages and positive effects of the present invention are:

[0032] 1. The present invention improves the proliferation level and metabolic capacity of fermentation bacteria in edible fungus culture medium by adding bacteriostatic factors.

[0033] 2. Use mold fermentation to produce cellulase, and perform enzymatic reactions in the later stage of fermentation, which helps to destroy the fungal cell wall matrix and promote the dissolution of polysaccharide components; yeast proliferation utilizes monosaccharides in the fermentation matrix to reduce the ineffective components in the final extract; lactic acid bacteria ferment to produce lactic acid, and the low pH environment changes the cell permeability, promoting the dissolution of intracellular active ingredients such as polysaccharides.

[0034] 3. Edible fungi are rich in protein nutrients. Through the co-fermentation of three bacteria systems, edible fungi not only produce a new secondary metabolite - GABA after metabolism, but also increase the content of bioactive substances such as polysaccharides, adenosine, and polyphenols. After fermentation, ultrasonic extraction promotes cell lysis, so that a large amount of intracellular active ingredients are dissolved.

[0035] 4. The process of the present invention is simple, easy to operate, and easy to realize industrial production. Compared with unfermented edible fungus extracts, fermented edible fungus extracts have significantly improved effects in lowering blood lipids and blood sugar, and can be used to prepare products with related functions, and are widely used in the fields of food, health products, medicine, etc. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 A chromatogram showing the content of adenosine in the edible fungus fermentation extract provided in an embodiment of the present invention;

[0037] Figure 2 This is the proliferation effect of the bacteriostatic factor provided in the embodiment of the present invention on the fermentation bacteria. DETAILED DESCRIPTION

[0038] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0039] The edible fungi of the present invention can be selected from at least one of Hericium erinaceus, Ganoderma lucidum, Cordyceps sinensis, Matsutake, Lentinula edodes, Grifola frondosa, Inonotus obliquus, Agaricus blazei, Coprinus comatus, Agaricus bisporus, and Pleurotus eryngii. In order to facilitate the explanation of the implementation effect of this patent, the following examples and comparative examples take Ganoderma lucidum as an example of the edible fungi raw material, but it can be understood that any of the above edible fungi can be selected for replacement according to the specific methods of the following examples.

[0040] Example 1

[0041] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 80-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:5, and bacteriostatic factors [3 g / L composite extract (wolfberry extract: yam extract: chrysanthemum extract = 5:3:2), 10 g / L prebiotics (fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2), 7 g / L peptone, 2.4 g / L sodium glutamate, 5 mg / L pyridoxal phosphate] were added, the pH was adjusted to 6.5, and after stirring evenly, the mixture was sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0042] S2: According to the conventional process, CICC 2626 Trichoderma reesei, CICC 24512 Bacillus subtilis, CICC1338 Saccharomyces cerevisiae, CICC 32883 Saccharomyces cerevisiae, CICC 25096 Lactobacillus rhamnosus, and CICC 22158 Lactobacillus plantarum were activated respectively, and the number of viable bacteria in the bacterial solution after activation was not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 1:1:2:3:2:1, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 7% of the total volume of the fermentation substrate, and ferment for a total of 72 hours. The first stage of fermentation is at a temperature of 28°C, a rotation speed of 180rpm, and fermentation for 20 hours; the second stage of fermentation is at 28°C, a rotation speed of 100rpm, and fermentation for 30 hours; the third stage of fermentation is at 35°C, and static fermentation is allowed to ferment for 18 hours, during which the pH changes to 4.0; the fourth stage of fermentation is at a temperature of 65°C, a rotation speed of 150rpm, and enzymatic reaction for 4 hours. Post-sterilization terminates the fermentation to obtain the fermentation product;

[0043] S3: The fermentation product is subjected to ultrasonic extraction, extracted at 25 kHz for 20 min, filtered by plate and frame, concentrated to obtain the fruiting body fermentation extract, and vacuum dried at 70° C. and passed through a 100-mesh sieve to obtain the edible fungus fermentation extract.

[0044] Example 2

[0045] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 100-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:10, and bacteriostatic factors [15 g / L composite extract (wolfberry extract: yam extract: chrysanthemum extract = 5:3:2), 20 g / L prebiotics (fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2), 10 g / L peptone, 4 g / L sodium glutamate, 10 mg / L pyridoxal phosphate] were added, the pH was adjusted to 7.0, and after stirring evenly, the mixture was sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0046] S2: According to the conventional process, CICC 2626 Trichoderma reesei, CICC 24512 Bacillus subtilis, CICC1338 Saccharomyces cerevisiae, CICC 32883 Saccharomyces cerevisiae, CICC 25096 Lactobacillus rhamnosus, and CICC 22158 Lactobacillus plantarum were activated respectively, and the number of viable bacteria in the bacterial solution after activation was not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 1:1:2:2:2:2, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 12% of the total volume of the fermentation substrate, and ferment for a total of 120 hours. The temperature of the first stage of fermentation is 32°C, the speed is 200rpm, and the fermentation is carried out for 36 hours; the second stage of fermentation is 32°C, the speed is 130rpm, and the fermentation is carried out for 48 hours; the third stage of fermentation is 39°C, and the fermentation is allowed to stand for 30 hours. During the fermentation process, the pH changes to 4.3; in the fourth stage of fermentation, the temperature is raised to 75°C, the speed is 180rpm, and the enzymatic reaction is carried out for 6 hours. The fermentation is terminated by post-sterilization to obtain the fermentation product;

[0047] S3: The fermentation product is subjected to ultrasonic extraction, extracted at 30 kHz for 30 min, filtered by plate and frame, concentrated to obtain the fruiting body fermentation extract, and vacuum dried at 75° C. and passed through a 100-mesh sieve to obtain the edible fungus fermentation extract.

[0048] Example 3

[0049] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 80-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:7, and bacteriostatic factors [12 g / L composite extract (wolfberry extract: yam extract: chrysanthemum extract = 5:3:2), 18 g / L prebiotics (fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2), 8 g / L peptone, 3.5 g / L sodium glutamate, 8 mg / L pyridoxal phosphate] were added, the pH was adjusted to 6.5, and the mixture was evenly stirred and sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0050] S2: According to the conventional process, CICC 2626 Trichoderma reesei, CICC 24512 Bacillus subtilis, CICC1338 Saccharomyces cerevisiae, CICC 32883 Saccharomyces cerevisiae, CICC 25096 Lactobacillus rhamnosus, and CICC 22158 Lactobacillus plantarum were activated respectively, and the number of viable bacteria in the bacterial solution after activation was not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 1:1:3:2:1:2, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 10% of the total volume of the fermentation substrate, and ferment for a total of 86 hours. The first stage of fermentation is at a temperature of 30°C, a rotation speed of 180rpm, and fermentation for 32 hours; the second stage of fermentation is at 30°C, a rotation speed of 120rpm, and fermentation for 33 hours; the third stage of fermentation is at 37°C, and static fermentation is allowed to ferment for 18 hours. During the fermentation process, the pH changes to 4.0; in the fourth stage of fermentation, the temperature is raised to 70°C, the rotation speed is 160rpm, and the enzymatic reaction is carried out for 3 hours. The fermentation is terminated by post-sterilization to obtain the fermentation product;

[0051] S3: The fermentation product is subjected to ultrasonic extraction, extracted at 25 kHz for 25 min, filtered by plate and frame, concentrated to obtain a fruiting body fermentation extract, and vacuum dried at 70° C. and passed through a 100-mesh sieve to obtain an edible fungus fermentation extract.

[0052] Example 4

[0053] Compared with Example 3, the difference is that the co-fermentation bacteria in step S2 are CICC 2626 Trichoderma reesei, CICC1338 Saccharomyces cerevisiae, and CICC 25096 Lactobacillus rhamnosus.

[0054] The details are as follows:

[0055] S2: Activate CICC 2626 Trichoderma reesei, CICC 1338 Saccharomyces cerevisiae, and CICC 25096 Lactobacillus rhamnosus according to conventional processes, and the number of viable bacteria in the bacterial solution after activation is not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 2:5:3, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 10% of the total volume of the fermentation substrate, and ferment for a total of 86 hours. The temperature of the first stage of fermentation is 30°C, the rotation speed is 180rpm, and the fermentation is carried out for 32 hours; the second stage of fermentation is 30°C, the rotation speed is 120rpm, and the fermentation is carried out for 33 hours; the third stage of fermentation is 37°C, and the fermentation is allowed to stand for 18 hours. During the fermentation process, the pH changes to 4.0; in the fourth stage of fermentation, the temperature is raised to 70°C, the rotation speed is 160rpm, and the enzymatic reaction is carried out for 3 hours. The fermentation is terminated by post-sterilization to obtain the fermentation product;

[0056] Example 5

[0057] Compared with Example 3, the difference is that the co-fermentation bacteria in step S2 are CICC 24512 Bacillus subtilis, CICC 32883 Saccharomyces cerevisiae, and CICC 22158 Lactobacillus plantarum.

[0058] The details are as follows:

[0059] S2: Activate CICC 24512 Bacillus subtilis, CICC 32883 Saccharomyces cerevisiae, and CICC22158 Lactobacillus plantarum according to conventional processes. The number of live bacteria in the activated bacterial solution is not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 2:5:3, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 10% of the total volume of the fermentation substrate, and ferment for a total of 86 hours. The temperature of the first stage of fermentation is 30°C, the rotation speed is 180rpm, and the fermentation is carried out for 32 hours; the second stage of fermentation is 30°C, the rotation speed is 120rpm, and the fermentation is carried out for 33 hours; the third stage of fermentation is 37°C, and the fermentation is allowed to stand for 18 hours. During the fermentation process, the pH changes to 4.0; in the fourth stage of fermentation, the temperature is raised to 70°C, the rotation speed is 160rpm, and the enzymatic reaction is carried out for 3 hours. The fermentation is terminated by post-sterilization to obtain the fermentation product;

[0060] Comparative Example 1

[0061] Compared with Example 3, the difference is that no composite extract is added to the bacteriostatic factor in step S1.

[0062] The details are as follows:

[0063] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 80-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:7, and bacteriostatic factors [18 g / L prebiotics (fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2), 8 g / L peptone, 3.5 g / L sodium glutamate, 8 mg / L pyridoxal phosphate] were added, and the pH was adjusted to 6.5. After stirring evenly, the mixture was sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0064] Comparative Example 2

[0065] Compared with Example 3, the difference is that no prebiotics are added to the bacteriostatic factors in step S1.

[0066] The details are as follows:

[0067] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 80-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:7, and a bacteriostatic factor [12 g / L composite extract (wolfberry extract: yam extract: chrysanthemum extract = 5:3:2), peptone 8 g / L, sodium glutamate 3.5 g / L, pyridoxal phosphate 8 mg / L] was added, and the pH was adjusted to 6.5. After stirring evenly, the mixture was sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0068] Comparative Example 3

[0069] Compared with Example 3, the difference is that in step S1, sodium glutamate and pyridoxal phosphate are not added as the bacteriostatic factors.

[0070] The details are as follows:

[0071] S1: Ganoderma lucidum fruiting bodies were crushed and sieved to obtain 80-mesh crushed material, which was soaked in water at a material-liquid ratio of 1:7, and bacteriostatic factors [12 g / L composite extract (wolfberry extract: yam extract: chrysanthemum extract = 5:3:2), 18 g / L prebiotics (fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2), peptone 8 g / L] were added, and the pH was adjusted to 6.5. After stirring evenly, the mixture was sterilized at 115°C for 30 min to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0072] Comparative Example 4

[0073] Compared with Example 3, the difference is that no bacteriostatic factor is added in step S1.

[0074] The details are as follows:

[0075] S1: Grind and sieve the fruiting bodies of Ganoderma lucidum to obtain 80-mesh crushed material, soak it in water at a material-liquid ratio of 1:7, adjust the pH to 6.5, stir evenly and sterilize at 115° C. for 30 minutes to obtain a fermentation substrate containing edible fungus fruiting bodies;

[0076] Comparative Example 5

[0077] Compared with Example 3, the difference is that the fourth fermentation stage is not performed in step S2.

[0078] The details are as follows:

[0079] S2: According to the conventional process, CICC 2626 Trichoderma reesei, CICC 24512 Bacillus subtilis, CICC1338 Saccharomyces cerevisiae, CICC 32883 Saccharomyces cerevisiae, CICC 25096 Lactobacillus rhamnosus, and CICC 22158 Lactobacillus plantarum were activated respectively, and the number of viable bacteria in the bacterial solution after activation was not less than 10 8 CFU / mL, mix them under sterile conditions at a volume ratio of 1:1:3:2:1:2, and inoculate the mixed bacterial liquid into the fermenter at an inoculation rate of 10% of the total volume of the fermentation substrate, and ferment for a total of 86 hours. The temperature of the first stage of fermentation is 30°C, the speed is 180rpm, and the fermentation is carried out for 32 hours; the second stage of fermentation is 30°C, the speed is 120rpm, and the fermentation is carried out for 33 hours; the third stage of fermentation is 37°C, and the fermentation is allowed to stand for 18 hours. During the fermentation process, the pH changes to 4.0. After sterilization, the fermentation is terminated to obtain the fermentation product;

[0080] Comparative Example 6

[0081] The difference compared with Example 3 is that no co-fermentation treatment was performed.

[0082] The details are as follows:

[0083] S1: Grind and sieve the Ganoderma lucidum fruiting body to obtain 80-mesh crushed material, and soak it in water at a material-liquid ratio of 1:7;

[0084] S2: Heat to 70°C, speed 160 rpm, react for 3 hours;

[0085] S3: ultrasonic extraction was performed, extraction was performed at 25 kHz for 25 min, plate and frame filtration was performed, concentration was performed, vacuum drying was performed at 70° C., and then sieved through a 100-mesh sieve to obtain an edible fungus extract.

[0086] Comparative Example 7

[0087] Compared with Example 3, the difference is that no ultrasonic treatment is performed in step S3.

[0088] The details are as follows:

[0089] S3: The fermentation product is subjected to plate-and-frame filtration treatment to be concentrated to obtain a fruiting body fermentation extract, which is vacuum dried at 70° C. and then passed through a 100-mesh sieve to obtain an edible fungus fermentation extract.

[0090] Comparative Example 8

[0091] Compared with Comparative Example 1, the difference is that co-fermentation and ultrasonic treatment are not performed.

[0092] The details are as follows:

[0093] S1: Grind and sieve the Ganoderma lucidum fruiting body to obtain 80-mesh crushed material, and soak it in water at a material-liquid ratio of 1:7;

[0094] S2: Heat to 70°C, speed 160 rpm, react for 3 hours;

[0095] S3: performing plate and frame filtration treatment, concentrating, vacuum drying at 70° C., and then passing through a 100-mesh sieve to obtain an edible fungus extract.

[0096] Test Example 1

[0097] The contents of crude polysaccharides, β-glucan, polyphenols and adenosine in the edible fungus fermentation extracts obtained in Examples 1-5 and Comparative Examples 1-8 of the present invention were detected.

[0098] The determination of crude polysaccharides refers to the determination of crude polysaccharides in edible fungi in NY / T 1676, and the monosaccharides (disaccharides) are removed by alcohol precipitation. The polysaccharides are first hydrolyzed into monosaccharides under the action of sulfuric acid, and then rapidly dehydrated to form uronic acid derivatives, which react with phenol to produce orange-yellow substances with characteristic absorption at 490nm, and are quantitatively compared with the standard curve.

[0099] The β-glucan content was determined by using the Megazyme K-YBGL kit. The total glucan and α-glucan contents were determined and the β-glucan content was obtained by subtracting them.

[0100] The determination of polyphenols refers to the tea polyphenol content determination method in Appendix A of GB / T 31740.2 Tea Products Part 2: Tea Polyphenols. Folin phenol reagent oxidizes the -OH group in tea polyphenols and develops a blue color with a maximum absorption wavelength of λ at 765nm. Gallic acid is used as a calibration standard to quantify the polyphenol content in the sample.

[0101] Adenosine was determined by high performance liquid chromatography-external standard method according to NY / T 2116, the method for determination of cordycepin and adenosine in cordyceps products.

[0102] Table 1 - Crude polysaccharide, β-glucan, polyphenol and adenosine contents of products of Examples 1-5 and Comparative Examples 1-8

[0103]

[0104] It can be seen from Table 1 that compared with Example 3, Comparative Examples 1, 2 and 4 lack the bacteriostatic factor component, which leads to slow growth of the fermented bacteria, further weakening the fermentation effect, and a variety of active ingredients cannot be enriched or dissolved by fermentation, and the final product index is poor, which shows the necessity of using bacteriostatic factors to proliferate the fermented bacteria in the present invention; Comparative Examples 6 and 8 lack the co-fermentation step, so the edible fungi are only extracted by conventional processes, and the obtained product indexes are all low, but Comparative Example 6 uses ultrasound-assisted extraction to further improve the dissolution of effective ingredients in the water extraction process, so the index status is better than that of Comparative Example 8, which shows the effective effect brought by the co-fermentation process of the present invention; Compared with Example 3, the results of Comparative Example 7 also show that ultrasound assistance in the present invention can also effectively promote the dissolution of effective ingredients in the bacteria after the end of the previous process.

[0105] Test Example 2

[0106] The GABA content of the edible fungus fermentation extracts obtained in Examples 1-5 and Comparative Examples 1-8 of the present invention was tested. The GABA content was determined by referring to the high performance liquid chromatography method in Appendix A of QB / T 5633.7 γ-aminobutyric acid.

[0107] Table 2 - GABA content of products of Examples 1-5 and Comparative Examples 1-8

[0108]

[0109] Compared with Example 3, Comparative Example 3 lacks the substrate and coenzyme necessary for synthesizing GABA, resulting in an extremely low GABA content in the product, indicating the necessity of bacteriostatic factors for the additional secondary metabolites produced in the edible fungus fermentation extract; Examples 4 and 5 also have a certain degree of decrease in GABA content due to the use of fewer strains; Comparative Examples 6 and 8 also have extremely low GABA content in the product due to the lack of a co-fermentation step, which also shows the necessity of fermentation strains in promoting the production of secondary metabolites.

[0110] Test Example 3: Application of the present invention in lowering blood sugar and blood lipids

[0111] The edible fungus fermentation extract of Example 3 and the edible fungus extract of Comparative Example 8 were used as drug samples, and metformin was used as a control sample, and the study was carried out according to the following test method.

[0112] 1. Modeling

[0113] SPF SD male rats aged 4-5 weeks and weighing 180-200g were randomly selected. After one week of adaptive feeding with ordinary feed, they were randomly divided into a blank group and a type 2 diabetes model group. During the experiment, the blank group was fed with ordinary feed, and the model group was fed with a high-sugar and high-fat feed (59.5% ordinary feed, 10% egg yolk powder, 10% lard, 20% sucrose, 0.5% sodium cholate). Feeding for 4-6 weeks induced insulin resistance. After 4 weeks, all rats were fasted for 12 hours but not water. The blank group was intraperitoneally injected with an equal volume of sodium citrate buffer, and the model group was intraperitoneally injected with a small dose of streptozotocin (STZ, 40 mg / kg). After injection, the blood of the rats was collected through the tail vein every 72 hours to measure fasting blood sugar. When the FBG value was greater than 11.1mmol / L at the same time for 3 consecutive days, the type 2 diabetes model was successfully established. For rats with FBG values ​​less than 11.1mmol / L, STZ (40mg / kg) was injected intraperitoneally.

[0114] 2. Grouping

[0115] According to the blood glucose values ​​of the model, the model group rats were randomly divided into a hyperglycemia model group, a metformin group, a low-dose group of Example 3, a medium-dose group of Example 3, a high-dose group of Example 3, a comparative example 8 group, and a blank group, with 10 rats in each group. The blank group and the hyperglycemia model group were gavaged with an equal amount of normal saline, the metformin group was gavaged with 150 mg / kg of metformin, the three dose groups of Example 3 were gavaged with 50, 150, and 300 mg / kg of edible fungus fermentation extract, respectively, and the comparative example 8 group was gavaged with 150 mg / kg of edible fungus extract, once a day, for 4 consecutive weeks.

[0116] 3. Index detection

[0117] Body weight and fasting blood glucose were measured once a week before and during administration. On the day of blood collection, rats in each group fasted but not water for 12 hours. After the administration, the rats were killed and blood was collected to detect fasting blood glucose and serum lipid indexes (serum total cholesterol TC, serum triglycerides TG, serum low-density lipoprotein cholesterol LDL-C and serum high-density lipoprotein cholesterol HDL-C). The test data were expressed as mean ± standard deviation.

[0118] Table 3 - Body weight changes of SD rats in each experimental group

[0119]

[0120]

[0121] The rats in the blank group gained weight. Compared with the hyperglycemia model, the weight loss rate of the rats intervened by metformin, the edible fungus fermentation extract of Example 3 and the edible fungus extract of Comparative Example 8 was significantly slowed down, among which the high-dose edible fungus fermentation extract group had a better effect.

[0122] Table 4 - Effects of edible fungus (fermentation) extracts on fasting blood glucose in STD-induced diabetic SD rats

[0123]

[0124] Before administration, the blood glucose of the rats in the hyperglycemia model group was significantly increased compared with the blank group. After four weeks of intragastric administration, the fasting blood glucose of each dosage group in Example 3 was significantly reduced compared with the hyperglycemia model group, and the blood glucose lowering effect of the high-dose group was better than that of the medium-dose group and the low-dose group, and the blood glucose of the rats in the high-dose group decreased over time, showing a time-dependency. The fasting blood glucose of the comparative example 8 group was also significantly reduced, but the effect was not as good as that of the fermented extract of Example 3.

[0125] Table 5 - Effects of edible fungus (fermentation) extracts on blood lipids in STD-induced diabetic SD rats

[0126]

[0127] Compared with the blank group, the TC, TG, and LDL-C levels of the hyperglycemia model group were significantly increased, and the HDL-C content was slightly higher than that of the blank group, but there was no significant difference, which indicated that long-term high-sugar and high-fat diet led to lipid metabolism disorders in rats. Compared with the hyperglycemia model group, the TC, TG, and LDL-C levels of the metformin group, each dose group of Example 3, and the comparative example 8 group all showed a downward trend and a dose-dependent relationship. The higher the dose of the edible fungus fermentation extract, the better the intervention effect, and the fermentation extract was better than the unfermented extract. There was no significant change in the HDL-C level.

[0128] In summary, after gavage of edible fungus fermented extract to hyperglycemic model rats, the rats' body weight, blood sugar and serum lipid indexes were alleviated, and the effect was better than that of unfermented edible fungus extract. This shows that the edible fungus fermented extract of the present invention has an auxiliary hypoglycemic effect, can be used to prepare products with related functions, and is widely used in the fields of food, health products, medicine, etc.

Claims

1. A method for preparing an edible fungus fermentation extract, characterized in that: Prepared according to the following steps: The edible fungus fruiting bodies are crushed and sieved to obtain 80-100 mesh crushed materials, which are soaked in water at a material-liquid ratio of 1:5-10, bacteriostatic factors are added, the pH is adjusted to 6.5±0.5, and the mixture is stirred evenly and sterilized at high temperature to obtain a fermentation substrate containing the edible fungus fruiting bodies; The activated mold liquid, yeast liquid and lactic acid bacteria liquid are added into a fermentation tank according to a certain ratio, fermented for 72 to 120 hours, and then sterilized to terminate the fermentation to obtain a fermentation product; The fermentation product is subjected to ultrasonic extraction and plate-and-frame filtration treatment, concentrated to obtain a fruiting body fermentation extract, and auxiliary materials are added or not, and the product is dried and sieved to obtain an edible fungus fermentation extract.

2. The preparation method according to claim 1, characterized in that: The edible fungus is selected from at least one of Hericium erinaceus, Ganoderma lucidum, Cordyceps sinensis, Matsutake, Lentinula edodes, Grifola frondosa, Inonotus obliquus, Agaricus blazei, Coprinus comatus, Agaricus bisporus and Pleurotus eryngii.

3. The preparation method according to claim 1, characterized in that: The bacteriostatic factors include: 3-15 g / L compound extract, 10-20 g / L prebiotics, 7-10 g / L peptone, 2.4-4 g / L sodium glutamate, 5-10 mg / L pyridoxal phosphate; among which: The composite extract is wolfberry extract: yam extract: chrysanthemum extract = 5:3:2, w / w; Prebiotics are fructooligosaccharide: galacto-oligosaccharide: polydextrose = 4:4:2, w / w.

4. The preparation method according to claim 1, characterized in that: The mold is selected from at least one of CICC 2626 Trichoderma reesei and CICC 24512 Bacillus subtilis; the yeast is selected from at least one of CICC 1338 and CICC 32883 Saccharomyces cerevisiae; and the lactic acid bacteria is selected from at least one of CICC 25096 Lactobacillus rhamnosus and CICC 22158 Lactobacillus plantarum.

5. The preparation method according to claim 4, characterized in that: When inoculating mold solution, yeast solution and lactic acid bacteria solution, the number of live bacteria in the solution shall not be less than 10 8 CFU / mL, the total inoculation amount is 7% to 12% of the total volume of the fermentation liquid, and the inoculation volume ratio of mold, yeast and lactic acid bacteria liquid is 1 to 2:4 to 5:3 to 4.

6. The preparation method according to claim 1, characterized in that: The co-fermentation process consists of four stages: The dominant bacteria in the first stage of fermentation are molds, the fermentation temperature is 30±2℃, the rotation speed is 180~200rpm, and the pH changes to 5.5±0.5 during the fermentation process; The dominant strain in the second stage fermentation is yeast, the fermentation temperature is 30±2℃, the rotation speed is 100~130rpm, and the pH remains basically unchanged during the fermentation process; The dominant bacteria in the third stage fermentation were lactic acid bacteria, the fermentation temperature was 37±2℃, the fermentation was allowed to stand, and the pH changed to 4.0±0.5 during the fermentation process; The temperature is raised to 70±5℃ in the fourth stage, and the rotation speed is 150~180rpm.

7. The preparation method according to claim 1, characterized in that: The auxiliary material in the drying process is selected from at least one of maltodextrin, starch, resistant dextrin and polydextrose.

8. Edible fungus fermentation extract, characterized in that The method is prepared by any one of claims 1 to 7.

9. The edible fungus fermentation extract according to claim 8, characterized in that: The edible fungus fermentation extract has a crude polysaccharide content of 10-40%, a beta-glucan content of 10-30%, a total polyphenol content of 1-1.5%, adenosine content of 0.8-1.2%, and a GABA content of 2.5-4 mg / g.

10. Use of the edible fungus fermentation extract according to claim 8 or 9 in functional foods, health products or medicines for auxiliary treatment of lowering blood sugar, lowering blood lipids and promoting sleep.

Citation Information

Cited By

  • Preparation method and application of cordyceps sinensis fermentation product

    CN120227299A

  • Preparation method and application of Cordyceps fermentation product

    CN120227299B

  • Preparation method of crocodile ginseng anti-fatigue active polypeptide liquid

    CN122229192A